TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 52 filers reported holding TYRA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,186,140 | -20.5% | 1,393,329 | -1.7% | 2.31% | -32.2% |
| Q2 2023 | $24,131,476 | +6.0% | 1,416,998 | 0.0% | 3.40% | -13.1% |
| Q1 2023 | $22,771,158 | +111.4% | 1,416,998 | 0.0% | 3.92% | +129.3% |
| Q4 2022 | $10,769,185 | -13.5% | 1,416,998 | 0.0% | 1.71% | -22.0% |
| Q3 2022 | $12,455,000 | +22.9% | 1,416,998 | 0.0% | 2.19% | -5.6% |
| Q2 2022 | $10,132,000 | -26.3% | 1,416,998 | +10.3% | 2.32% | -28.7% |
| Q1 2022 | $13,749,000 | +51.4% | 1,284,990 | +99.1% | 3.25% | +8.6% |
| Q4 2021 | $9,080,000 | +3.4% | 645,349 | +29.3% | 2.99% | -6.2% |
| Q3 2021 | $8,778,000 | – | 499,040 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $75,102,147 | 53.19% |
| Nextech Invest Ltd. | 2,518,582 | $42,891,451 | 14.58% |
| TCG Crossover Management, LLC | 1,989,103 | $33,874,424 | 5.56% |
| Boxer Capital, LLC | 6,448,359 | $109,816 | 5.09% |
| Fairmount Funds Management LLC | 1,416,998 | $24,131,476 | 3.40% |
| RA Capital Management | 7,236,454 | $123,236,812 | 2.33% |
| BVF INC/IL | 2,739,595 | $46,655,303 | 1.30% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $17,507,061 | 1.05% |
| Auour Investments LLC | 85,020 | $1,447,891 | 0.62% |
| Artia Global Partners LP | 45,253 | $770,659 | 0.27% |